Trump's FDA chief pick Makary to face overhauling agency, keeping Kennedy happy
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, will be tasked with maintaining the agency's gold standard status among international drug regulators while contending with cost cuts,

BioNTech, FDA and Malaria

U.S. FDA places clinical hold on BioNTech's malaria vaccine study
 · 22hBioSpace
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
 · 1dFierce Biotech
BioNTech's RNA malaria vaccine trial hit by FDA hold
Trump’s FDA nominee, Marty Makary, faces his first test
Marty Makary, Trump’s pick for FDA director, faces his first test as he testifies before the Senate health committee.
FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
Food and Drug Administration nominee Dr. Marty Makary is known for his contrarian views and fiery criticism of traditional medical institutions.
Trump Administration Cancels Meeting of FDA Vaccine Advisers, Risking Flu-Shot Delay
The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season.
Flu vaccine panel meeting canceled, US FDA confirms
The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the composition of this year's flu vaccine has been canceled and the regulator would instead make recommendations later.
FDA cancels flu vaccine meeting and now health experts are worried
The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.
FDA cancels meeting to choose flu vaccine strain
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.
STAT6d
FDA cancels vaccine advisory committee meeting
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in their shots for the next flu season.